Health

Cambridge Scientists Detect Signs of Dementia Nine Years Ahead of Diagnosis

Man With Alzheimer’s Dementia

The study found that cognitive changes could appear years before diagnoses of neurodegenerative diseases.

Dementia could be detected nine years earlier.

Researchers from the University of Cambridge have shown that it is possible to identify indicators of brain impairment in individuals up to nine years before they are given a dementia-related disease diagnosis.

The researchers examined data from the UK Biobank and discovered impairment in a number of areas, including problem-solving and numerical recall, across a variety of conditions. The findings were reported in a study that was recently published in Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association.

The results suggest that in the future, at-risk individuals may be tested to help determine which ones may benefit from interventions to lower their chance of developing one of the conditions or to help identify people appropriate for enrollment in clinical trials for new treatments.

For dementia and other neurodegenerative diseases like Parkinson’s disease, there are currently very few effective treatments available. This is due in part to the fact that these conditions are often only identified until symptoms appear, even though the underlying neurodegeneration may have started years or even decades before. This means that it could already be too late to change the course of the disease by the time people enroll in clinical trials.

Until now, it has been unclear whether it might be possible to detect changes in brain function before the onset of symptoms. To help answer this question, researchers at the University of Cambridge and Cambridge University Hospitals NHS Foundation Trust turned to UK Biobank, a biomedical database and research resource containing anonymized genetic, lifestyle, and health information from half a million UK participants aged 40-69.

As well as collecting information on participants’ health and disease diagnoses, UK Biobank collected data from a battery of tests including problem-solving, memory, reaction times, and grip strength, as well as data on weight loss and gain and on the number of falls. This allowed them to look back to see whether any signs were present at baseline – that is, when measurements were first collected from participants (between five and nine years prior to diagnosis).

People who went on to develop Alzheimer’s disease scored more poorly compared to healthy individuals when it came to problem-solving tasks, reaction times, remembering lists of numbers, prospective memory (our ability to remember to do something later on), and pair matching. This was also the case for people who developed a rarer form of dementia known as frontotemporal dementia.

People who went on to develop Alzheimer’s were more likely than healthy adults to have had a fall in the previous 12 months. Those patients who went on to develop a rare neurological condition known as progressive supranuclear palsy (PSP), which affects balance, were more than twice as likely as healthy individuals to have had a fall.

For every condition studied – including Parkinson’s disease and dementia with Lewy bodies – patients reported poorer overall health at baseline.

First author Nol Swaddiwudhipong, a junior doctor at the University of Cambridge, said: “When we looked back at patients’ histories, it became clear that they were showing some cognitive impairment several years before their symptoms became obvious enough to prompt a diagnosis. The impairments were often subtle but across a number of aspects of cognition. This is a step towards us being able to screen people who are at greatest risk – for example, people over 50 or those who have high blood pressure or do not do enough exercise – and intervene at an earlier stage to help them reduce their risk.”

Senior author Dr. Tim Rittman from the Department of Clinical Neurosciences at the University of Cambridge added: “People should not be unduly worried if, for example, they are not good at recalling numbers. Even some healthy individuals will naturally score better or worse than their peers. But we would encourage anyone who has any concerns or notices that their memory or recall is getting worse to speak to their GP.”

Dr. Rittman said the findings could also help identify people who can participate in clinical trials for potential new treatments. “The problem with clinical trials is that by necessity they often recruit patients with a diagnosis, but we know that by this point they are already some way down the road and their condition cannot be stopped. If we can find these individuals early enough, we’ll have a better chance of seeing if the drugs are effective.”

Reference: “Pre-diagnostic cognitive and functional impairment in multiple sporadic neurodegenerative diseases” by Nol Swaddiwudhipong, David J. Whiteside, Frank H. Hezemans, Duncan Street, James B. Rowe and Timothy Rittman, 12 October 2022, Alzheimer’s & Dementia.
DOI: 10.1002/alz.12802

The study was funded by the Medical Research Council with support from the NIHR Cambridge Biomedical Research Centre.

Share

View Comments

  • I would also like to participate in the study. My daughter thinks I am showing signs now. I live with her. I am 70.
    I also am a pot smoker.

  • 41-yr-old black female plagued with dementia like symptoms for years. Seen by number of doctors to include neurologist for dementia - it was not diagnosed, but was not ruled out. Diagnosed with frontal lobe epilepsy.

    Would love to be a part of the trial.

  • I am very interested. My Mom is dealing with PSP. Diagnosis given about 3 to 4 years ago. I remember, in hindsight, Mom have little problems over 15 years ago

  • I am very interested in this study and would like to take part. I’m 61 with some problems now and one is no smell and nerve damage. Loss of strength and balance.

  • I'm so happy to see the research that the scientists in this disease. I lost my husband from Alzheimer's 18 months ago at the age of 68, leaving me a widow at the age of 63. This disease is horrible to watch him not remember his family or friend. He did remember who I was until the two days before he pass. Thank you for those researching this dieses.

    • I am 58. Noticing some issues with recall and saying wrong word. My dad had dementia, I would be interested in finding out about participating in the study.

  • My dad has dementia. I have been telling my physical doctor that my simple mind is getting worse. That I need testing to see what wrong.

  • Alzheimers and dementia run on my mothers side. I'm 57 and see signs already. I have 5 signs of alzheimers is very possible

    • My Dad is in stage 6 Dementia, 5 of my Uncle's(Dad's brothers) passed from Dementia. Depression majority of my adult life, smoker & walk 20-25 mins 2xs a day, nerve damage, sleep issues, 49yo female.

  • MyGrandma and Uncle on my Mom’s side of the family died with Parkinson’s disease. I’m 62 and exercise 5 days a week and at a good weight but am beginning to see evidence that I’m on the same path as my relatives. I’d be pleased to participate in your research.

By
University of Cambridge

Recent Posts

Rare Fossilized Feathers Reveal Secrets of Ancient Paleontology Hotspot

The early Cretaceous bird fossils hold key information about the ancient ecosystem of Jehol Biota.…

February 5, 2023

Unprecedented Precision – New DNA Sequencing Method Lifts “Veil” From Genome Black Box

Many life-saving medications interact directly with DNA to treat illnesses like cancer, but scientists have…

February 5, 2023

Overcoming Children’s Peanut Allergies: Boiled Peanuts Show Promise

According to the results of a clinical trial at Flinders University and SAHMRI, boiling peanuts…

February 5, 2023

Unlocking the Secrets of Cellular Uptake: Revolutionary Discovery Paves Way for New Cancer and Disease Treatments

Revolutionary bitopic inhibitors pave the way for innovative disease treatment strategies. The development of drugs…

February 5, 2023

NASA’s Interstellar Mapping and Acceleration Probe Completes Critical Design Review

NASA’s Interstellar Mapping and Acceleration Probe (IMAP) mission held a critical design review (CDR) last…

February 5, 2023

Can Neuroimaging Reveal the Roots of Psychiatric Disorders Like PTSD?

A Yale study says not yet. A recent study led by Yale University highlights that…

February 5, 2023